SynthesisDigestive diseases and sciences2025
An Audit of Indications for Endoscopic Submucosal Dissection for Colorectal Lesions in North America: A Systematic Review and Meta-Analysis.
Synthesis in Digestive diseases and sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endoscopic mucosal resection (EMR) is a safe and effective treatment for most large colorectal lesions Endoscopic submucosal dissection (ESD) can be performed in cases suspicious for superficial submucosal invas. This decision is often operator dependent and based on optical diagnosis of polyp morphology and surface vascular and pit pattern. Here, we conduct a systematic review and meta-analysis of ESD performed for colorectal lesions in North America to evaluate the proportion of ESD performed for benign colorectal lesions. A comprehensive literature search of multiple electronic databases was conducted to identify all studies assessing ESD for colorectal lesions in North America. The primary outcome was pooled proportion of ESD performed for benign colorectal lesions based on histopathology. Secondary outcomes included procedure-related outcomes and adverse events of ESD. Pooled proportion of ESD for benign lesions was 83.81% (95% CI: 78.8-88.2; I
Indexed as
Identifiers
40531262What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.